Wyked Labs Recalls Dietary Supplements that May Violate Federal Law
Wyked Labs is recalling a number of dietary supplements at the urging of the U.S. Food and Drug Administration (FDA), which believes the product violates federal law.
The FDA believes that the supplements are prohormone products that bear a similarity to anabolic steroids and do not meet the requirements of the Dietary Supplement Health and Education Act of 1994.
Use or consumption of products containing methylated anabolic steroids may cause acute liver injury, which is known to be a possible harmful effect of using steroid-containing products. In addition, abuse of anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
Neither have the FDA nor has Wyked Labs received reports of illness. "Wyked Labs' decision to implement this recall should not be construed as an admission that its sale of these products was in violation of the law," wrote the company in a release.
The following products have been recalled:
- Wyked Labs Ml-Alpha
- Wyked Labs M14-Ment
- Wyked Labs Halo-70
- Wyked Labs 7-Ment Alpha
- Wyked Labs Estrastain
- Wyked Labs Swoll-250
- Formexx Black (an Anabolic Science Labs product)
- Slim X Lean (an Anabolic Science Labs product)
The recalled supplements were distributed nationwide through various retail outlets and via the internet.
The manufacture and distribution of all the recalled products has been stopped. Consumers, distributors, and retailers with any of the recalled products should stop using them and immediately return them to the place of purchase.
Contact your health care professional if you have experienced any adverse effects. Adverse reactions or quality problems experienced with the use of the recalled Products may be reported to the FDA's MedWatch Adverse Event Reporting program.